FirmaIQ
Org.nr 992 709 014 2022 → 2023 Year-over-year analysis

3P BIOTECH NORWAY AS: årsregnskap 2023 vs 2022

Shrank 100% on revenue, weaker earnings, cash halved-plus

approved 2024-06-18; registry 2024-08-12; journal 2024 724082

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2023 with 2022 for 3P BIOTECH NORWAY AS. Revenue 1.12m NOK → 1 121 NOK (-99.9%). Net result -35.4k NOK → -49.1k NOK. Equity 307.9k NOK → 258.8k NOK.

Pressures included: revenue fell; operating result weakened; net result weakened.

Net tougher year on the published lines.

At a glance

Scorecard

Revenue
1.12m NOK 1 121 NOK
-99.9%
Operating result
-24.3k NOK -48.4k NOK
-99.0%
Net result
-35.4k NOK -49.1k NOK
-38.7%
Equity
307.9k NOK 258.8k NOK
-15.9%
Cash
129 NOK -283.1k NOK
-219579.8%

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 1.12m NOK to 1 121 NOK (-99.9% YoY). Calculated

  • ↓

    Operating result weakened

    Operating result -24.3k NOK → -48.4k NOK (op. margin -2.2% → -4319.2%). Calculated

  • ↓

    Net result weakened

    Net result -35.4k NOK → -49.1k NOK (net margin -3.2% → -4379.3%). Calculated

  • ↓

    Equity eroded

    Book equity 307.9k NOK → 258.8k NOK. Calculated

  • ↓

    Cash fell

    Bank deposits 129 NOK → -283.1k NOK (-219579.8% YoY). Calculated